Acronyms Flashcards
ADR
Adverse Drug Reaction
AEs
Adverse Events
ALCOA
Attributable, Legible, Contemporaneous, Original, Accurate
BIMO
Bioresearch Monitoring
BLA
Biologics License Application
CAPA
Corrective Action/Preventive Action
CBC
Complete Blood Count
CBER
Center for Biologics Evaluation and Research
CDA
Confidential Disclosure Agreement
CDER
Center for Drug Evaluation and Research
CDRH
Center for Devices and Radiological Health
CDSCO
Central Drug Standard Control Organization
CFR
Code of Federal Regulations
cGMP
Current Good Manufacturing Practices
cGTP
Current Good Tissue Practice
CIOMS
Council for International Organizations of Medical Sciences
CMS
Centers for Medicare and Medicaid Services
CoC
Certificate of Confidentiality
CPT
Current Procedure Terminology
CRA
Clinical Research Associate
CQMP
Clinical Quality Management Plan
CRFs
Case Report Forms
CRO
Clinical Research Organization
CV
Curriculum Vitae
DBT
Department of Biotechnology
DCC
Drug Consultative Committee
DMAC
Drugs Medical Advisory Committee
DOJ
Department of Justice
DSMB
Data Safety Monitoring Board
DTAB
Drugs Technical Advisory Board
EC
Ethics Committee
eCRF
Electronic Case Report Form
EDC
Electronic Data Capture System
EHR
Electronic Health Record
EKG
Electrocardiogram
EMA
European Medicines Agency
ePHI
Electronic Protected Health Information
ESCs
Embryonic Stem Cells
EU
European Union
FDA
US Food and Drug Administration
FIH
First In Human
Form FDA 1572
Statement of the Inspection
Form FDA 482
Notice of Inspection
Form FDA 483
Statement of Observation
FWA
Federal Wide Assurance
GCP
Good Clinical Practice
HCT/P
Human Cell Tissue/Products
hESC
Human Embryonic Stem Cells
HHS
US Department of Health and Human Services
HIPAA
Health Insurance Portability and Accountability Act
HIV
Human Immunodeficiency Virus
IB
Investigator Brochure
ICD
Informed Consent Document
ICFs
Informed Consent Forms
ICH
International Conference of Harmonisation
IDE
Investigational Device Exemption
IEC
Independent Ethics Committee
IND
Investigational New Drug
IP
Intellectual Property
iPSC
Induced Pluripotent Stem Cells
IRB
Institutional Review Board
IV
Intravenous
LAR
Legally Authorized Representative
LCD
Local Coverage Determination
MDUFA
Medical Device User Fee and Modernization Act
MOHFW
Ministry of Health & Family Welfare
MRI
Magnetic Resonance Imaging
MTP
Medical Termination of Pregnancy
NABH
National Accreditation Board for Hospitals and Health Care Providers
NAI
No action Indicated
NCD
National Coverage Determination
NCI
National Cancer Institute
NDA
New Drug Application
NGSCR
National Guidelines for Stem Cell Research
NIDPOE
Notice of Initiation of Disqualification Proceedings and Opportunity to Explain
NIH
National Institutes of Health
NSR
NonSignificant Risk
OAI
Official Action Indicated
OCP
Office of Combination Products
OCR
Office for Civil Rights
OHRP
Office of Human Research Protection
OIG
Office of the Inspector General
PHI
Protected Health Information
PHS
Public Health Service
PI
Principle Investigator
PIS
Patient Information Sheet
PMA
Premarket Approval
PMOA
Primary Mode of Action
QA
Quality Assurance
QC
Quality Control
RA
Rheumatoid Arthritis
RBM
Risk-Based Monitoring
RCA
Root Cause Analysis
SADR
Serious Adverse Drug Reactions
SAEs
Serious Adverse Events
SE
Schedule of Events
SOC
Standard of Care
SOP
Standard Operating Procedure
SR
Significant Risk
SSC
Somatic Stem Cells
URL
Uniform Resource Locator
VAI
Voluntary Action Indicated
WHO
World Health Organization